These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 17598405

  • 1. In vitro effect of subinhibitory concentrations of ceftazidime and meropenem on the serum sensitivity of Pseudomonas aeruginosa strains.
    Drenjancević D, Vranes J, Bedenić B, Sakić-Zdravcević K.
    Coll Antropol; 2007 Mar; 31(1):221-5. PubMed ID: 17598405
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
    Pruekprasert P, Tunyapanit W.
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002-2004.
    Unal S, Garcia-Rodriguez JA.
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):265-71. PubMed ID: 16360550
    [Abstract] [Full Text] [Related]

  • 6. [Comparative bactericidal activity of imipenem and other antibiotics against Pseudomonas aeruginosa].
    Thabaut A, Meyran M.
    Pathol Biol (Paris); 1988 May; 36(5):472-6. PubMed ID: 3136428
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa.
    Oie S, Uematsu T, Sawa A, Mizuno H, Tomita M, Ishida S, Okano Y, Kamiya A.
    J Antimicrob Chemother; 2003 Dec; 52(6):911-4. PubMed ID: 14585851
    [Abstract] [Full Text] [Related]

  • 9. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
    Dambrauskiene A, Adukauskiene D, Jeroch J, Vitkauskiene A.
    Medicina (Kaunas); 2009 Dec; 45(1):1-7. PubMed ID: 19223699
    [Abstract] [Full Text] [Related]

  • 10. Development of resistance in wild-type and hypermutable Pseudomonas aeruginosa strains exposed to clinical pharmacokinetic profiles of meropenem and ceftazidime simulated in vitro.
    Henrichfreise B, Wiegand I, Luhmer-Becker I, Wiedemann B.
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3642-9. PubMed ID: 17682103
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Pseudomonas aeruginosa: a multicentric study of antibiotic resistance (1999-2000)].
    Kalai S, Jouaihia W, Mahjoubi F, Ghozzi R, Thabet L, Ben Rejeb S, Hammami A, Kechrid A, Ben Hassen A.
    Tunis Med; 2004 Dec; 82(12):1070-4. PubMed ID: 15822507
    [Abstract] [Full Text] [Related]

  • 13. Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology.
    Visalli MA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1998 Apr; 42(4):953-5. PubMed ID: 9559819
    [Abstract] [Full Text] [Related]

  • 14. [Application of a millipore membrane transfer method to the study of the activity of 4 beta-lactams on Pseudomonas aeruginosa].
    Denis C, Lesage D, Delisle-Mizon F, Vergez P, Daguet GL.
    Pathol Biol (Paris); 1984 May; 32(5):415-20. PubMed ID: 6429614
    [Abstract] [Full Text] [Related]

  • 15. Effects of imipenem and meropenem on serum sensitivity and surface hydrophobicity of Klebsiella pneumoniae.
    Hostacká A.
    Arzneimittelforschung; 1998 Nov; 48(11):1101-3. PubMed ID: 9850433
    [Abstract] [Full Text] [Related]

  • 16. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Lee MY, Ko KS, Song JH, Peck KR.
    J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. MYSTIC Europe 2007: activity of meropenem and other broad-spectrum agents against nosocomial isolates.
    Turner PJ.
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):217-22. PubMed ID: 19070453
    [Abstract] [Full Text] [Related]

  • 19. Is there a pharmacodynamic need for the use of continuous versus intermittent infusion with ceftazidime against Pseudomonas aeruginosa? An in vitro pharmacodynamic model.
    Alou L, Aguilar L, Sevillano D, Giménez MJ, Echeverría O, Gómez-Lus ML, Prieto J.
    J Antimicrob Chemother; 2005 Feb; 55(2):209-13. PubMed ID: 15650000
    [Abstract] [Full Text] [Related]

  • 20. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.
    Gad GF, El-Domany RA, Zaki S, Ashour HM.
    J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.